NEW

On March 31, 2022, the United States Food and Drug Administration (FDA) Office of Prescription Drug Promotion (OPDP) sent an…

In mid-April 2022, Alabama announced that it reached $276 million in settlements with Johnson & Johnson, McKesson Corp., and…

Atopic dermatitis (AD) is a chronic, relapsing inflammatory skin condition that can have a significant impact on patient health…

A bipartisan group of lawmakers are pushing for bipartisan legislation that would both lower insulin prices and prohibit drug…

Policy and Medicine Compliance Update is our monthly compliance publication designed to help compliance professionals go in depth…

In April 2022, the United States House of Representatives’ Committee on Oversight and Reform issued a report, finding that 22…

While COVID-19 has impacted almost every facet of our lives over the last few years, one area that it didn’t seem to have a huge…

On April 28, 2022, the United States Centers for Medicare and Medicaid Services (CMS) and Department of Health and Human Services…

In mid-April 2022, two marketers were sentenced in federal court to twelve months of probation and hundreds of thousands of…

Recently, the Department of Justice (DOJ) announced a $5.79 million settlement with PillPack, an Amazon subsidiary, in a fraud…